A phase 1/2 study of carfilzomib in combination with lenalidomide and low-dose dexamethasone as a frontline treatment for multiple myeloma
- Resource Type
- Article
- Authors
- Jakubowiak, Andrzej J.; Dytfeld, Dominik; Griffith, Kent A.; Lebovic, Daniel; Vesole, David H.; Jagannath, Sundar; Al-Zoubi, Ammar; Anderson, Tara; Nordgren, Brian; Detweiler-Short, Kristen; Stockerl-Goldstein, Keith; Ahmed, Asra; Jobkar, Terri; Durecki, Diane E.; McDonnell, Kathryn; Mietzel, Melissa; Couriel, Daniel; Kaminski, Mark; Vij, Ravi
- Source
- In Blood 30 August 2012 120(9):1801-1809
- Subject
- Language
- ISSN
- 0006-4971